Search results

Blog

Up Close and Personal with Dr. Gaetano Morelli, MD

Mar 31, 2021

Get to know Dr. Morelli, MD, Altasciences' Chief Medical Officer.
Press Release

WCCT Global (an Altasciences Company) Clinic Expansion

Mar 23, 2021
Blog

Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

Feb 28, 2021
- Clinical Trials
- Science and Health
Press Release

Altasciences Performs Phase I Studies for FDA Approval of Vibegron

Feb 23, 2021
ISSUE NO. 16 — Microsampling in Drug Development

Dec 15, 2020
Blog

Clinical Applications of Hallucinogens, Dissociatives and other Schedule I Drugs

Nov 25, 2020

Hallucinogens, dissociatives and other Schedule I drugs are increasingly being found to have a clinical application in a number of therapeutic areas. Recent approvals, background, and related case studies in this month's blog.
Scientific Publication

Assessment of Receptor Occupancy via Flow Cytometry: Benefits and Pitfalls of Two Common Approaches

Nov 16, 2020
- Bioanalysis